资金流向方面，深港通医疗(港币)（983036）指数成份股当日主力资金净流出合计2.3亿元，游资资金净 流入合计3861.61万元，散户资金净流入合计1.91亿元。成份股资金流向详情见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，12月9日，深港通医疗(港币)（983036）指数报收于4338.72点，跌1.52%，成交81.17亿 元，换手率0.99%。当日该指数成份股中，上涨的有7家，麦克奥迪以1.87%的涨幅领涨，下跌的有50 家，先健科技以8.38%的跌幅领跌。 深港通医疗(港币)（983036）指数十大成份股详情如下： ...

Core Insights - The Shenzhen-Hong Kong Stock Connect Medical Index (983036) closed at 4406.89 points, down 0.24%, with a trading volume of HKD 7.939 billion and a turnover rate of 0.88% [1] - Among the index constituents, 23 stocks rose while 34 stocks fell, with Yiyang Sunshine leading the gainers at 3.98% and Jinxin Fertility leading the decliners at 3.89% [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Stock Connect Medical Index are as follows: - Mindray Medical (sz300760) holds a weight of 14.56%, latest price at HKD 200.05, down 1.16%, with a market cap of HKD 242.549 billion [1] - Aier Eye Hospital (sz300015) has a weight of 11.62%, latest price at HKD 11.40, up 0.89%, with a market cap of HKD 106.31 billion [1] - Lepu Medical (sz300003) has a weight of 4.85%, latest price at HKD 15.89, up 0.38%, with a market cap of HKD 29.292 billion [1] - Aimeike (sz300896) has a weight of 4.80%, latest price at HKD 142.81, down 0.11%, with a market cap of HKD 43.213 billion [1] - Yuyue Medical (sz002223) has a weight of 4.66%, latest price at HKD 35.84, down 0.83%, with a market cap of HKD 35.929 billion [1] - Yingke Medical (sz300677) has a weight of 3.64%, latest price at HKD 43.72, up 0.97%, with a market cap of HKD 28.644 billion [1] - Furuide (sz300049) has a weight of 3.59%, latest price at HKD 70.75, up 0.71%, with a market cap of HKD 18.747 billion [1] - Meinian Onehealth (sz002044) has a weight of 3.58%, latest price at HKD 5.13, down 0.58%, with a market cap of HKD 20.08 billion [1] - Sinopharm (hk01099) has a weight of 3.35%, latest price at HKD 18.51, down 0.97%, with a market cap of HKD 57.767 billion [1] - Ping An Good Doctor (hk01833) has a weight of 2.63%, latest price at HKD 13.18, up 0.21%, with a market cap of HKD 28.495 billion [1] Capital Flow Analysis - The index constituents experienced a net outflow of main funds totaling HKD 230 million, while retail investors saw a net inflow of HKD 268 million [1] - Detailed capital flow for specific stocks shows: - Furuide (sz300049) had a main fund net inflow of HKD 8.7323 million, with retail outflows of HKD 3.3726 million [2] - Aier Eye Hospital (sz300015) had a main fund net inflow of HKD 6.6536 million, with retail outflows of HKD 1.8752 million [2] - Lepu Medical (sz300003) had a main fund net inflow of HKD 3.7716 million, with retail outflows of HKD 0.7273 million [2]

证券之星消息，12月5日，深港通医疗（983035）指数报收于4509.21点，涨0.83%，成交69.36亿元，换 手率0.85%。当日该指数成份股中，上涨的有39家，健康之路以7.52%的涨幅领涨，下跌的有16家，一脉 阳光以13.68%的跌幅领跌。 深港通医疗（983035）指数十大成份股详情如下： | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | --- | | sz300760 | 迈瑞医疗 | 14.56% | 202.39 | 1.20% | | 2453.86 | 医药生物 | | sz300015 | 爱尔眼科 | 11.62% | 11.30 | 0.62% | | 1053.77 | 医药生物 | | sz300003 | 乐普医疗 | 4.85% | 15.83 | 1.09% | | 291.81 | 医药生物 | | sz300896 | 爱美客 | 4.80% | 142.97 | 1.82% | 1 | 432.62 | 美容护理 | | ...

资金流向方面，深港通医疗(港币)（983036）指数成份股当日主力资金净流出合计2.24亿元，游资资金净 流出合计2064.25万元，散户资金净流入合计2.44亿元。成份股资金流向详情见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入(元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 300049 福瑞股份 | | 2710.53万 | 4.58% | -2326.67万 | -3.93% | -383.85万 | -0.65% | | 002044 | 美年健康 | 2672.84万 | 11.22% | -1892.21万 | -7.95% | -780.63万 | -3.28% | | 301267 | 华厦服科 | 1778.89万 | 15.22% | -247.70万 | -2.12% | -1531.19万 | -13.10% | | 000516 国际医学 | | - 97.68万 | 1.83% | 183.26万 | 3.44% | -28 ...

证券之星消息，12月4日，深港通医疗（983035）指数报收于4472.99点，跌0.53%，成交59.38亿元，换 手率0.69%。当日该指数成份股中，上涨的有18家，微创机器人-B以5.48%的涨幅领涨，下跌的有38家， 一脉阳光以7.29%的跌幅领跌。 深港通医疗（983035）指数十大成份股详情如下： | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | --- | | sz300760 | 迈瑞医疗 | 14.56% | 200.00 | 0.25% | | 2424.88 | 一 医药生物 | | sz300015 | 爰尔眼科 | 11.62% | 11.23 | -1.06% | | 1047.24 | 医药生物 | | sz300003 | 乐普医疗 | 4.85% | 15.66 | -0.89% | | 288.68 | 医药生物 | | sz300896 | 爱美客 | 4.80% | 140.41 | -2.29% | S | 424.87 | 美 ...

资金流向方面，深港通医疗(港币)（983036）指数成份股当日主力资金净流出合计3.3亿元，游资资金净 流入合计979.64万元，散户资金净流入合计3.2亿元。成份股资金流向详情见下表： 证券之星消息，12月4日，深港通医疗(港币)（983036）指数报收于4382.53点，跌0.57%，成交65.4亿 元，换手率0.69%。当日该指数成份股中，上涨的有18家，微创机器人-B以5.48%的涨幅领涨，下跌的有 38家，一脉阳光以7.29%的跌幅领跌。 深港通医疗(港币)（983036）指数十大成份股详情如下： | 深港通医疗(港币)指数 十大成份股 | | --- | | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | | sz300760 | 迈瑞医疗 | 14.56% | 200.00 | 0.25% | 2424.88 | 医药生物 | | sz300015 | 爰尔眼科 | 11.62% | 11.23 | -1.06% | 1047.24 | 医药生物 | | sz3 ...

Core Viewpoint - The financial performance of Kangtong Medical shows a significant decline in revenue and net profit, indicating potential challenges for the company in the near future [2]. Group 1: Financial Performance - As of November 28, 2025, Kangtong Medical reported a revenue of 344 million yuan, a year-on-year decrease of 30.06% [2]. - The company recorded a net profit of -10.21 million yuan, reflecting a year-on-year decrease of 150.92% [2]. - Cumulative cash dividends since the A-share listing amount to 48.9973 million yuan [3]. Group 2: Shareholder and Market Activity - As of December 3, 2025, the number of shareholders for Kangtong Medical is 7,481, a decrease of 5.24% from the previous period [2]. - The average number of circulating shares per shareholder is 8,426, which has increased by 5.53% compared to the last period [2]. - On December 3, 2025, the stock price of Kangtong Medical fell by 0.72%, with a trading volume of 19.146 million yuan [1]. Group 3: Financing and Margin Trading - On December 3, 2025, Kangtong Medical had a financing buy-in of 543,400 yuan, with a net financing buy of -148,120 yuan [1]. - The total financing and margin trading balance for Kangtong Medical is 29.0609 million yuan, with the financing balance accounting for 1.90% of the circulating market value [1]. - The company’s margin trading balance is at a high level, with a margin balance of 2,197 yuan and a margin stock quantity of 100 shares [1]. Group 4: Business Overview - Kangtong Medical, established on January 13, 1998, is located in Chengdu, Sichuan Province, and was listed on July 25, 2023 [1]. - The company's main business involves providing medical institutions with overall solutions centered on medical gas systems and clean operating rooms [1]. - The revenue composition includes: 55.69% from clean medical equipment and systems, 37.30% from medical gas equipment and systems, 4.06% from medical equipment and other product sales, 2.81% from operation and maintenance services, and 0.14% from other sources [1].

Core Points - The Shenzhen-Hong Kong Medical Index (983035) closed at 4495.04 points, down 0.66%, with a trading volume of 6.607 billion yuan and a turnover rate of 0.76% [1] - Among the index constituents, 11 stocks rose while 46 fell, with Xianjian Technology leading the gainers at 5.38% and Health Road leading the decliners at 5.3% [1] Index Constituents - The top ten constituents of the Shenzhen-Hong Kong Medical Index include: - Mindray Medical (14.56% weight) at 199.50 yuan, down 0.56% [1] - Aier Eye Hospital (11.62% weight) at 11.35 yuan, down 1.30% [1] - Lejin Medical (4.85% weight) at 15.80 yuan, up 0.38% [1] - Aimeike (4.80% weight) at 143.70 yuan, down 0.94% [1] - Yuyue Medical (4.66% weight) at 36.03 yuan, up 0.59% [1] - Yingke Medical (3.64% weight) at 43.22 yuan, up 1.93% [1] - Furuishi (3.59% weight) at 66.98 yuan, down 0.56% [1] - Meinian Health (3.58% weight) at 5.13 yuan, down 1.54% [1] - Sinopharm (3.35% weight) at 18.52 yuan, down 0.59% [1] - Ping An Good Doctor (2.63% weight) at 13.20 yuan, down 1.43% [1] Capital Flow - The index constituents experienced a net outflow of 301 million yuan from institutional investors, while retail investors saw a net inflow of 174 million yuan [3] - Notable capital flows include: - Meihua Medical with a net inflow of 21.18 million yuan from institutional investors [3] - Kefu Medical with a net inflow of 14.75 million yuan from institutional investors [3] - Yuyue Medical with a net inflow of 6.16 million yuan from institutional investors [3] Recent Adjustments - The Shenzhen-Hong Kong Medical Index has undergone adjustments, with one new stock added in the last ten days [3]

证券之星消息，12月3日，深港通医疗(港币)（983036）指数报收于4406.01点，跌0.65%，成交72.8亿 元，换手率0.76%。当日该指数成份股中，上涨的有11家，先健科技以5.38%的涨幅领涨，下跌的有46 家，健康之路以5.3%的跌幅领跌。 深港通医疗(港币)（983036）指数十大成份股详情如下： | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | | sz300760 | 迈瑞医疗 | 14.56% | 199.50 | -0.56% | 2418.82 | 医药生物 | | sz300015 | 爰尔眼科 | 11.62% | 11.35 | -1.30% | 1058.43 | 医药生物 | | sz300003 | 乐晋医疗 | 4.85% | 15.80 | 0.38% | 291.26 | 医药生物 | | sz300896 | 爱美客 | 4.80% | 143.70 | -0.94% | 434.82 | 美容护理 | | sz002223 ...

Group 1 - The core viewpoint of the news is that 港通医疗 (Kangtong Medical) is experiencing a decline in financial performance, with significant decreases in both revenue and net profit year-on-year [2] - As of December 2, 港通医疗's stock price decreased by 0.23%, with a trading volume of 22.5 million yuan, and a net financing purchase of 518,800 yuan [1] - The company's financing balance is 30.54 million yuan, which is 1.98% of its market capitalization, indicating a low level compared to the past year [1] Group 2 - 港通医疗's revenue for the period from January to September 2025 was 344 million yuan, representing a year-on-year decrease of 30.06% [2] - The company reported a net profit attributable to shareholders of -10.21 million yuan, a significant decline of 150.92% compared to the previous year [2] - The company has distributed a total of 48.99 million yuan in dividends since its A-share listing [3] Group 3 - As of November 28, 港通医疗 had 7,481 shareholders, a decrease of 5.24% from the previous period, while the average number of circulating shares per person increased by 5.53% to 8,426 shares [2] - The top ten circulating shareholders include 诺安多策略混合A (Noah Multi-Strategy Mixed A), which holds 725,100 shares as a new shareholder [3] - The company's main business involves providing medical institutions with overall solutions centered on medical gas systems and clean operating rooms, with revenue contributions of 55.69% from clean equipment and systems, 37.30% from medical gas equipment and systems, and 4.06% from other medical equipment sales [1]